datastreet.in

Insilico Medicine secures $2.75 billion drug collaboration with Eli Lilly

Pharmaceutical companies are increasingly turning to AI to accelerate R&D, betting on new modelling tools and automated labs to unlock efficiency gains across their pipeline

Source :- Companies Read More

Share it :

Leave a Reply

Your email address will not be published. Required fields are marked *